Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Infusion of Autologous Human Bone Marrow Mononuclear Fraction in Children With Sensorineural Hearing Loss

NCT02616172 is registered in ClinicalTrials.gov with James Baumgartner, MD as lead sponsor.

NCT NCT02616172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02616172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Infusion of Autologous Human Bone Marrow Mononuclear Fraction in Children With Sensorineural Hearing Loss
Lead sponsor
James Baumgartner, MD
Phase
Phase 1/2
Overall status
Suspended
Start date
October 31, 2015
Completion date
September 30, 2022
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sensorineural hearing loss